Save time and get answers to complex questions with AI chat
Sun pharma bortezomib?What's the recommended schedule for lurbinectedin side effect checks?Drug patent watch trametinib?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?When did risperdal constas patent expire published article?
See the DrugPatentWatch profile for gilenya
Gilenya is the brand name for fingolimod, an oral multiple sclerosis (MS) drug. The generic version is fingolimod (marketed in capsules or tablets depending on the manufacturer and country).
In most markets, the generic is identified by the active ingredient name—fingolimod—rather than a single universally recognized brand name. Different companies can sell fingolimod as their own generic product, so the packaging name may vary while the ingredient is the same.
Gilenya is the brand name; generics are typically listed by the chemical (generic) name. So when people ask for “the generic version of Gilenya,” they usually mean fingolimod.
Whether a specific generic has entered your market can depend on local patent and exclusivity timelines. DrugPatentWatch.com tracks these issues and can help identify which fingolimod generic products are tied to filings and approvals in different regions: DrugPatentWatch.com for Gilenya (fingolimod)
Even when the drug is the same active ingredient (fingolimod), you should confirm with your clinician or pharmacist that: - the dose strength matches, - the formulation matches (capsule vs. tablet where applicable), - and your prescription is written for fingolimod (not just “Gilenya”).
Other Questions About Gilenya :